Becton, Dickinson and Co (XSWX:BDX)
CHF 243.41 0 (0%) Market Cap: 63.44 Bil Enterprise Value: 78.37 Bil PE Ratio: 37.37 PB Ratio: 2.48 GF Score: 85/100

Becton Dickinson and Co at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 12:50PM GMT
Patrick Andrew Wood

Amazing. Thank you so much and welcome, everyone. Before we start, I get the fun disclosures, morganstanley.com/researchdisclosures. I'm just timing this right down, go there. I'm sure you all will, or you can reach out to your MS sales rep. Patrick Wood, U.S. med tech team. And welcome, everyone. Big thank you, of course, the entire BD team. Obviously, we've got Chris, we've got Mike, and we got Dave across the Head of Medical segment, across Life Sciences and of course, as CFO. Thank you so much for joining us and agreeing to do this.

Questions & Answers

Patrick Andrew Wood

Well, we'll we kick off with, how about 2024 margins? You guys are running a little bit ahead, I would say. See how the year closes, but maybe where you were hoping to be on the margin structure side of things. How are you thinking about the interplay between reinvestment and margins going forward?

Christopher J. DelOrefice
Becton, Dickinson and Company - Executive VP & CFO

Yes, yes. No, I appreciate the question. Thanks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot